By Sree Roy When starting people with narcolepsy and idiopathic hypersomnia on oxybates, sleep physicians know to individualize the treatment dosing based on each patient’s response as well as personal preference. A new study presented at SLEEP 2024 reinforces the importance of … [Read more...]
Enrollment Opens for Hypersomnia Data Collection Initiative
Summary: Global Genes’ RARE-X platform and the Sleep Consortium have launched the Sleep Data Collection Initiative, now open for enrollment. This initiative aims to gather and share patient-owned data on central disorders of hypersomnolence, such as narcolepsy and idiopathic … [Read more...]